Local Institution

Shenyang, Liaoning 110042

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Acute Ischemic Stroke, Atrial Fibrillation, Atrial Flutter, Breast Cancer, Cancer, Hepatocellular, Chronic Hepatitis B, Mesothelioma, Transient Ischemic Attack (TIA)

Studies at this site

• A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer — Completed
• Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients — Completed
• A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer — Completed
• A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel — Completed
• Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early